Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-09-29

Clinical Trial Update: A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on using botulinum toxin type A to treat axillary hyperhidrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Hyperhidrosis | Phase 4 | Status: COMPLETED